Nicholas Shungu named associate director for DEI at MUSC Hollings

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nicholas Shungu was named associate director for diversity, equity, and inclusion at MUSC Hollings Cancer Center. 

He will be focused on equity in patient care, research, education and staff recruitment.

“For me, as a primary care doctor, I wish that researchers had the foresight to prioritize the population that we know experiences worse outcomes. That would be an example of looking at things with an equity lens—making sure that a population that we know faces disparate outcomes is adequately or even overrepresented in studies,” Shungu said in a statement.

The MUSC College of Medicine is one of the most diverse medical colleges outside of historically black colleges and universities. Shungu hopes to encourage more underrepresented students to continue their training through residencies at MUSC Health. 

Shungu will also focus on MUSC’s growth throughout the state, through new hospitals and expanded partnerships.

Shungu began his new role on July 1.

Table of Contents

YOU MAY BE INTERESTED IN

Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, or anything other than straight and cisgender experience more chronic health conditions, disabilities, and other physical and cognitive limitations than non-LGBTQ+ cancer survivors; however, the prevalence of most conditions was highest among transgender or gender non-conforming individuals, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
Friends of Cancer Research characterized postmarketing requirements and commitments over the last decade. The perspective article, titled “An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials,” provides insights into FDA’s expectations for representation of race and ethnicity in oncology clinical trials.

Login